skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metabolism of guanido-labeled (C-14)arginine in rats, mice, and man

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5343386

(6-/sup 14/C)arginine, injected intraperitoneally into normal rats, was cleared from the plasma with biphasic decay kinetics. Urinary excretion was efficient (32% of the 25-..mu..Ci dose within the first 24 h) with no preferential tissue retention. In mice, the effective duration of the radiotracer's availability for protein biosynthesis was less than 30 min. When the tracer was administered iv to patients with multiple myeloma, it was similarly cleared from the plasma with biphasic kinetics, and was excreted rapidly in the urine (22% of the dose within the first 24 h). In patients, the guanido-tagged arginine labeled only tumor M component, and the labeling was most intense in patients who had far advanced disease. Estimated radiation dose to humans from a 100-..mu..Ci injection was 10 mrads. These studies demonstrate the feasibility of in vivo labeling with (6-/sup 14/C)arginine, with minimal radiation hazard, thus providing a simple, sensitive, and specific method for monitoring the synthesis of the plasmacytoma M component in patients with multiple myeloma.

Research Organization:
Johns Hopkins Univ., Baltimore, MD
OSTI ID:
5343386
Journal Information:
J. Nucl. Med.; (United States), Vol. 21:1
Country of Publication:
United States
Language:
English